Both in Pharmaceuticals
Marker Therapeutics vs Kyntra Bio
Over the past year MRKR returned −56.5% and KYNB returned −53.9%; their daily moves had a correlation of 0.17.
MRKR −56.5% KYNB −53.9%Growth of $1, one year, split-adjusted
| Metric | MRKR | KYNB |
|---|---|---|
| Price | $0.9001 | $4.38 |
| Market cap | $15.0M | $17.7M |
| Today | −8.15% | −4.16% |
| 1 month | −14.3% | −30.6% |
| 6 months | −42.3% | −39.2% |
| Year to date | −39.6% | — |
| 1 year | −8.9% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 6.4× | — |
| Net cash | $11.3M | $91.3M |
| Dividend yield | — | — |
| Volatility (60d) | 83.9% | 55.6% |
| Short % of float | 0.8% | 2.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).